United Health Products, Inc. (UEEC) shareholders
Close on Oct 19, 2026Market cap $10.25MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Wendy Beplate Irrevocable Trust | 18,000,000 | 7.20% | 13D (active) | Dec 17, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of UEEC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| SlateStone Wealth, LLC | 161,905 | 0.06% | $9.00K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brian David Thom | Chief Executive Officer, Director | 1,104,671 | 0.42% | Apr 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Brian David Thom Chief Executive Officer, Director | Apr 8, 2025 | Buy | +32,000 | $0.24 | $7.68K | 1,104,671 |
| Brian David Thom Chief Executive Officer, Director | Mar 31, 2025 | Buy | +18,000 | $0.26 | $4.68K | 1,072,671 |
| Brian David Thom Chief Executive Officer, Director | May 12, 2023 | Sale | −300,000 | $0.19 | $57.00K | 1,054,671 |
| Brian David Thom Chief Executive Officer, Director | Apr 17, 2023 | Award | +309,375 | $0.22 | $68.06K | 1,354,671 |
| Brian David Thom Chief Executive Officer, Director | Jan 13, 2023 | Award | +225,000 | $0.27 | $60.75K | 920,296 |
| Brian David Thom Chief Executive Officer, Director | Dec 23, 2022 | Sale | −201,400 | $0.21 | $42.29K | 695,296 |
| Brian David Thom Chief Executive Officer, Director | Dec 21, 2022 | Sale | −98,600 | $0.23 | $22.68K | 695,296 |
| Kristofer Heaton Principal Financial Officer | Oct 28, 2022 | Sale | −5,000 | $0.32 | $1.60K | 1,368,416 |
| Kristofer Heaton Principal Financial Officer | Oct 25, 2022 | Sale | −4,500 | $0.29 | $1.31K | 1,373,416 |
| Kristofer Heaton Principal Financial Officer | Sep 16, 2022 | Award | +125,000 | $0.30 | $37.50K | 1,377,916 |
| Brian David Thom Chief Executive Officer, Director | Sep 16, 2022 | Award | +150,000 | $0.30 | $45.00K | 1,112,141 |
| Brian David Thom Chief Executive Officer, Director | Jun 6, 2022 | Sale | −43,945 | $0.47 | $20.65K | 918,196 |
| Brian David Thom Chief Executive Officer, Director | Jun 3, 2022 | Sale | −56,055 | $0.49 | $27.47K | 962,141 |
| Brian David Thom Chief Executive Officer, Director | Jun 2, 2022 | Sale | −127,100 | $0.51 | $64.82K | 1,018,196 |
| Kristofer Heaton Principal Financial Officer | May 4, 2022 | Award | +250,000 | $0.42 | $105.00K | 1,252,916 |
| Brian David Thom Chief Executive Officer, Director | May 4, 2022 | Award | +300,000 | $0.42 | $126.00K | 1,145,296 |
| Brian David Thom Chief Executive Officer, Director | May 4, 2022 | Buy | +300,000 | $0.42 | $126.00K | 1,145,296 |
| Brian David Thom Chief Executive Officer, Director | Jan 3, 2022 | Sale | −220,000 | $0.54 | $118.80K | 1,148,658 |
| Brian David Thom Director | Dec 7, 2021 | Sale | −142,615 | $0.65 | $92.70K | 1,368,657 |
| Brian David Thom Chief Executive Officer, Director | Nov 22, 2021 | Sale | −134,000 | $0.76 | $101.84K | 1,444,205 |
| Brian David Thom Chief Executive Officer, Director | Nov 22, 2021 | Option exercise | +300,000 | $0.50 | $150.00K | 1,578,205 |
| Brian David Thom Chief Executive Officer, Director | Oct 14, 2021 | Buy | +27,102 | $0.95 | $25.75K | 1,278,205 |
| Brian David Thom Chief Executive Officer, Director | Mar 31, 2021 | Option exercise | +916,911 | $0.50 | $458.46K | 1,041,911 |
| Brian David Thom Chief Executive Officer, Director | Mar 31, 2021 | Option exercise | +303,361 | $0.50 | $151.68K | 1,345,272 |
| Louis Schiliro COO, Director | Mar 31, 2021 | Option exercise | +80,173 | $0.50 | $40.09K | 3,780,173 |
| Kristofer Heaton Principal Financial Officer, Director | Mar 31, 2021 | Option exercise | +52,666 | $0.50 | $26.33K | 457,666 |
| Douglas K. Beplate Director, 10% owner | Jan 6, 2021 | Award | +30,730,000 | $0.56 | $17.21M | 35,805,142 |
| Louis Schiliro Chief Operating Officer | Jan 6, 2021 | Award | +2,000,000 | $1.04 | $2.08M | 3,700,000 |
| Kristofer Heaton Principal Financial Officer | Jan 6, 2021 | Award | +100,000 | $1.04 | $104.00K | 405,000 |
| Louis Schiliro Chief Operating Officer | Jul 21, 2020 | Award | +1,500,000 | $0.71 | $1.07M | 1,700,000 |
| Douglas K. Beplate Chief Executive Officer, Director | Jul 21, 2020 | Award | +5,070,000 | $0.71 | $3.60M | 5,075,142 |
| Douglas K. Beplate CEO, Director | Nov 5, 2019 | Award | +400,000 | $0.97 | $388.00K | 712,142 |
| Nate Knight CFO, Director | Nov 5, 2019 | Award | +100,000 | $0.97 | $97.00K | 2,407,800 |
| Louis Schiliro Chief Operating Officer | Nov 5, 2019 | Award | +200,000 | $0.97 | $194.00K | 200,000 |
| Nate Knight Chief Financial Officer, Director | Nov 5, 2019 | Award | +100,000 | $0.97 | $97.00K | 2,300,000 |
| Robert J. Denser Director | Nov 5, 2019 | Award | +100,000 | $0.97 | $97.00K | 1,550,000 |
| Nate Knight CFO, Director | Apr 1, 2019 | Award | +1,600,000 | $0.94 | $1.50M | 2,307,800 |
| Nate Knight Director | Apr 1, 2019 | Award | +1,600,000 | $0.94 | $1.50M | 2,200,000 |
| Nate Knight CFO, Director | Feb 1, 2019 | Award | +100,000 | $1.00 | $100.00K | 707,800 |
| Nate Knight Director | Feb 1, 2019 | Award | +100,000 | $1.00 | $100.00K | 600,000 |
| Robert J. Denser Director | Feb 1, 2019 | Award | +100,000 | $1.00 | $100.00K | 1,450,000 |
| Nate Knight CFO, Director | Jan 8, 2019 | Sale | −20,000 | $0.70 | $14.00K | 607,800 |
| Douglas K. Beplate Director, 10% owner | Dec 19, 2018 | Gift | −209,000 | – | – | 2,504,047 |
| Douglas K. Beplate Director, 10% owner | Dec 17, 2018 | Sale | −555,000 | $0.50 | $277.50K | 2,753,047 |
| Douglas K. Beplate Director, 10% owner | Dec 17, 2018 | Gift | −40,000 | – | – | 2,713,047 |
| Douglas K. Beplate Director, 10% owner | Dec 11, 2018 | Sale | −90,000 | $0.50 | $45.00K | 3,308,047 |
| Douglas K. Beplate Director, 10% owner | Nov 29, 2018 | Sale | −400,000 | $0.50 | $200.00K | 3,398,047 |
| Douglas K. Beplate Director, 10% owner | Oct 31, 2018 | Gift | −100,000 | – | – | 3,798,047 |
| Douglas K. Beplate Director, 10% owner | Oct 25, 2018 | Gift | −240,000 | – | – | 3,898,047 |
| Douglas K. Beplate Director, 10% owner | Sep 17, 2018 | Gift | −1,000,000 | – | – | 4,138,047 |
| Douglas K. Beplate Director, 10% owner | Aug 6, 2018 | Sale | −300,000 | $0.33 | $99.00K | 5,138,047 |
| Douglas K. Beplate Director, 10% owner | Jul 10, 2018 | Gift | −243,650 | – | – | 5,438,047 |
| Douglas K. Beplate Director, 10% owner | Jun 14, 2018 | Inheritance | +1,512,000 | – | – | 5,728,447 |
| Douglas K. Beplate Director, 10% owner | Jun 14, 2018 | Gift | −46,750 | – | – | 5,681,697 |
| Douglas K. Beplate Director, 10% owner | May 4, 2018 | Sale | −148,653 | $0.69 | $102.57K | 4,216,447 |
| Douglas K. Beplate Director, 10% owner | Apr 18, 2018 | Gift | −225,253 | – | – | 4,365,000 |
| Douglas K. Beplate Director, 10% owner | Apr 10, 2018 | Gift | −200,000 | – | – | 4,540,253 |
| Douglas K. Beplate Director, 10% owner | Jan 10, 2018 | Gift | −150,000 | – | – | 4,740,253 |
| Nate Knight CFO, Director | Dec 17, 2017 | Sale | −100,000 | $0.54 | $54.00K | 628,800 |
| Robert J. Denser Director | Dec 15, 2017 | Award | +750,000 | $0.55 | $412.50K | 1,350,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of United Health Products's stock actually held short. Settlement fails (shares not delivered on time) peaked at 513,435 shares on Aug 31, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Brian David Thom Officer | May 10, 2023 | 300,000 | $75.00K | May 10, 2023 | STOCK AWARD |
See a number that looks wrong?